Acute myeloid leukemia-induced T-cell suppression can be reversed by inhibition of the MAPK pathway.
第一作者:
Kaycee B,Moshofsky
第一单位:
School of Medicine.
作者:
医学主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);疾病模型, 动物(Disease Models, Animal);基因表达谱(Gene Expression Profiling);人类(Humans);免疫调节(Immunomodulation);免疫表型分型(Immunophenotyping);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);淋巴细胞活化(Lymphocyte Activation);MAP激酶信号系统(MAP Kinase Signaling System);T淋巴细胞(T-Lymphocytes);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays);ras蛋白质类(ras Proteins)
DOI
10.1182/bloodadvances.2019000574
PMID
31648326
发布时间
2023-02-21
基金项目
U41 HG003751/HG/NHGRI NIH HHS/United States
TL1 TR002371/TR/NCATS NIH HHS/United States
U54 CA224019/CA/NCI NIH HHS/United States
P41 HG003751/HG/NHGRI NIH HHS/United States
U01 CA217862/CA/NCI NIH HHS/United States
- 浏览0
Blood advances
2019年3卷20期
3038-3051页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



